Incidence of chronic graft versus host disease using post-transplant cyclophosphamide in HLA-matched versus haploidentical donors

A single center study found that using post-transplant cyclophosphamide in patients who received allogeneic hematopoietic cell transplant resulted in a significantly lower incidence of chronic GvHD in patients who received it from matched related and matched unrelated donors compared to haploidentical donors.